Vigilant Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $17K | Hold |
300
| – | – | ﹤0.01% | 367 |
|
|
2023
Q1 | $14K | Hold |
300
| – | – | ﹤0.01% | 367 |
|
|
2022
Q4 | $12K | Sell |
300
-473
| -61% | -$18.9K | ﹤0.01% | 387 |
|
|
2022
Q3 | $51K | Hold |
773
| – | – | ﹤0.01% | 286 |
|
|
2022
Q2 | $47K | Hold |
773
| – | – | ﹤0.01% | 276 |
|
|
2022
Q1 | $49K | Hold |
773
| – | – | ﹤0.01% | 295 |
|
|
2021
Q4 | $59K | Hold |
773
| – | – | ﹤0.01% | 298 |
|
|
2021
Q3 | $87K | Hold |
773
| – | – | 0.01% | 220 |
|
|
2021
Q2 | $125K | Hold |
773
| – | – | 0.01% | 184 |
|
|
2021
Q1 | $94K | Buy |
773
+473
| +158% | +$57.5K | 0.01% | 199 |
|
|
2020
Q4 | $46K | Hold |
300
| – | – | ﹤0.01% | 231 |
|
|
2020
Q3 | $25K | Buy |
+300
| New | +$25K | ﹤0.01% | 265 |
|